Search Results - "Burstein, Aaron H."

Assessment of Azeliragon QTc Liability Through Integrated, Model‐Based Concentration QTc Analysis.

Authors: Burstein, Aaron H. Brantley, Scott J. Dunn, Imogene et al.

Source: Clinical Pharmacology in Drug Development. May2019, Vol. 8 Issue 4, p426-435. 10p.

Effect of TTP488 in patients with mild to moderate Alzheimer's disease.

Authors: Burstein, Aaron H. Grimes, Imogene Galasko, Douglas R. et al.

Source: BMC Neurology. 2014, Vol. 14 Issue 1, p1-17. 17p. 4 Charts, 3 Graphs.

Lack of Pharmacokinetic and Pharmacodynamic Interactions Between a Smoking Cessation Therapy, Varenicline, and Warfarin: An In Vivo and In Vitro Study.

Authors: Burstein, Aaron H. Clark, David J. O'Gorman, Melissa et al.

Source: Journal of Clinical Pharmacology. Nov2007, Vol. 47 Issue 11, p1421-1429. 9p.

This result is not displayed to guests.
Login for full access.

The Effect of Garlic Supplements on the Pharmacokinetics of Saquinavir.

Authors: Piscitelli, Stephen C. Burstein, Aaron H. Welden, Nada et al.

Source: Clinical Infectious Diseases. 1/15/2002, Vol. 34 Issue 2, p234. 5p.

Indinavir concentrations and St John's wort.

Authors: Piscitelli, Stephen C. Burstein, Aaron H. Chaitt, Doreen et al.

Source: Lancet. 2/12/2000, Vol. 355 Issue 9203, p547. 2p. 1 Graph.

Retrospective Evaluation of Commonly Used Equations to Predict Energy Expenditure in Mechanically Ventilated, Critically Ill Patients.

Authors: Alexander, Earnest Susla, Gregory M. Burstein, Aaron H. et al.

Source: Pharmacotherapy. Dec2004, Vol. 24 Issue 12, p1659-1667. 9p.

Pharmacokinetics, Safety, and Tolerability Following Multiple Oral Doses of Varenicline Under Various Titration Schedules in Elderly Nonsmokers.

Authors: Qinying Zhao Schwam, Elias Fullerton, Terence et al.

Source: Journal of Clinical Pharmacology. 04/01/2011, Vol. 51 Issue 4, p492-501. 10p.

Biomarkers in Alzheimer's disease clinical trials: 2025.

Authors: Osse AML Zhou Y Kinney JW et al.

Source: Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2026 Feb 17; Vol. 12 (1), pp. e70217. Date of Electronic Publication: 2026 Feb 17 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101650118 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-8737 (Electronic) Linking ISSN: 23528737 NLM ISO Abbreviation: Alzheimers Dement (N Y) Subsets: PubMed not MEDLINE

The impact of lecanemab and donanemab on future Alzheimer's disease clinical development.

Authors: Dickson, Samuel P. Mallinckrodt, Craig Burstein, Aaron H et al.

Source: Alzheimer's & dementia: the journal of the Alzheimer's Association Dec2024 Supplement; Vol. 20 (S6).

Journal Info: Publisher: Wiley-Blackwell ISSN: 1552-5260

Alzheimer Combination Therapies: Overview and Scenarios.

Authors: Cummings JL Burstein AH Fillit H

Source: The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2025 Dec; Vol. 12 (10), pp. 100328. Date of Electronic Publication: 2025 Oct 27.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE

Add-on combination therapy with monoclonal antibodies: Implications for drug development.

Authors: Cummings J Burstein AH Fillit H

Source: The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2025 Dec; Vol. 12 (10), pp. 100359. Date of Electronic Publication: 2025 Oct 27.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE

The impact of recent approvals on future alzheimer's disease clinical development: Statistical considerations for combination trials.

Authors: Dickson SP Mallinckrodt C Burstein AH et al.

Source: The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2025 Dec; Vol. 12 (10), pp. 100391. Date of Electronic Publication: 2025 Oct 27.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE

Harnessing combination therapy: Current treatments, recent advancements, and future directions in Alzheimer's disease.

Authors: Fillit HM Touchon J Vellas B et al.

Source: The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2025 Dec; Vol. 12 (10), pp. 100327. Date of Electronic Publication: 2025 Oct 27.

Publication Type: Editorial

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE; In Process

Effects of azeliragon on ADAS‐cog and CDR domains and individual items in patients with mild Alzheimer's disease and type 2 diabetes (T2D): Human/Human trials: Other.

Authors: Burstein, Aaron H. Dunn, Imogene Gooch, Ann M. et al.

Source: Alzheimer's & dementia: the journal of the Alzheimer's Association Dec2020 Supplement S11; Vol. 16 (11).

Journal Info: Publisher: Wiley-Blackwell ISSN: 1552-5260

O4‐11‐04: LINKING DIABETES AND ALZHEIMER'S DISEASE THROUGH RAGE: A RETROSPECTIVE ANALYSIS OF AZELIRAGON PHASE 2 AND PHASE 3 STUDIES.

Authors: Valcarce, Carmen Dunn, Imogene Burstein, Aaron H.

Source: Alzheimer's & dementia: the journal of the Alzheimer's Association Jul2019 7S Part 24; Vol. 15.

Journal Info: Publisher: Wiley-Blackwell ISSN: 1552-5260

A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation.

Authors: Faessel HM Obach RS Rollema H et al.

Source: Clinical pharmacokinetics [Clin Pharmacokinet] 2010 Dec; Vol. 49 (12), pp. 799-816.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE

Increase in tiagabine serum concentration with coadministration of gemfibrozil.

Authors: Burstein AH Boudreau EA Theodore WH

Source: The Annals of pharmacotherapy [Ann Pharmacother] 2009 Feb; Vol. 43 (2), pp. 379-82. Date of Electronic Publication: 2009 Feb 03.

Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Intramural

Journal Info: Publisher: Sage Country of Publication: United States NLM ID: 9203131 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-6270 (Electronic) Linking ISSN: 10600280 NLM ISO Abbreviation: Ann Pharmacother Subsets: MEDLINE

Herb-drug interactions and confounding in clinical trials.

Authors: Piscitelli SC Burstein AH

Source: Journal of herbal pharmacotherapy [J Herb Pharmacother] 2002; Vol. 2 (1), pp. 23-6.

Publication Type: Journal Article

Journal Info: Publisher: Haworth Herbal Press Country of Publication: England NLM ID: 100888586 Publication Model: Print Cited Medium: Print ISSN: 1522-8940 (Print) Linking ISSN: 15228940 NLM ISO Abbreviation: J Herb Pharmacother Subsets: PubMed not MEDLINE

Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy.

Authors: Landen JW Cohen S Billing CB Jr et al.

Source: Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2017 May 10; Vol. 3 (3), pp. 339-347. Date of Electronic Publication: 2017 May 10 (Print Publication: 2017).

Publication Type: Journal Article

Journal Info: Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101650118 Publication Model: eCollection Cited Medium: Print ISSN: 2352-8737 (Print) Linking ISSN: 23528737 NLM ISO Abbreviation: Alzheimers Dement (N Y) Subsets: PubMed not MEDLINE